Search Orphan Drug Designations and Approvals
-
| Generic Name: | resminostat mesilate |
|---|---|
| Date Designated: | 09/22/2023 |
| Orphan Designation: | Treatment of Cutaneous T-Cell Lymphoma (CTCL) |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
4SC AG Fraunhoferstrasse 22 Planegg-Martinsried 82152 Germany The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







